VSEE HEALTH, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that VSEE HEALTH, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.62M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $10.42M | Mar 31, 2026 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.62M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $10.42M | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | $3.35M | Aug 29, 2025 |
| FY2024 | Jun 30, 2024 | $3.33M | Aug 29, 2025 |
| FY2024 | Mar 31, 2024 | $1.62M | Aug 29, 2025 |
| FY2024 | Dec 31, 2023 | $5.77M | Aug 29, 2025 |
| FY2024 | Sep 30, 2023 | $1.43M | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | $1.27M | Aug 29, 2025 |
| FY2024 | Mar 31, 2023 | $1.58M | Aug 29, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.36M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $7.18M | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | $2.78M | Aug 29, 2025 |
| FY2024 | Jun 30, 2024 | $777.0K | Aug 29, 2025 |
| FY2024 | Mar 31, 2024 | $1.23M | Aug 29, 2025 |
| FY2024 | Dec 31, 2023 | $3.83M | Aug 29, 2025 |
| FY2024 | Sep 30, 2023 | $954.3K | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | $797.2K | Aug 29, 2025 |
| FY2024 | Mar 31, 2023 | $1.00M | Aug 29, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($14.71M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($57.70M) | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | ($53.92M) | Aug 29, 2025 |
| FY2024 | Jun 30, 2024 | ($634.1K) | Aug 29, 2025 |
| FY2024 | Mar 31, 2024 | $62.8K | Aug 29, 2025 |
| FY2024 | Dec 31, 2023 | ($3.76M) | Aug 29, 2025 |
| FY2024 | Sep 30, 2023 | ($189.8K) | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | ($503.3K) | Aug 29, 2025 |
| FY2024 | Mar 31, 2023 | ($530.0K) | Aug 29, 2025 |
| FY2023 | Dec 31, 2022 | ($3.24M) | Apr 12, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($9.58M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($62.15M) | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | ($58.29M) | Aug 29, 2025 |
| FY2024 | Jun 30, 2024 | ($932.5K) | Aug 29, 2025 |
| FY2024 | Mar 31, 2024 | $104.1K | Aug 29, 2025 |
| FY2024 | Dec 31, 2023 | ($1.87M) | Aug 29, 2025 |
| FY2024 | Sep 30, 2023 | ($353.1K) | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | ($689.8K) | Aug 29, 2025 |
| FY2024 | Mar 31, 2023 | ($715.9K) | Aug 29, 2025 |
| FY2023 | Dec 31, 2022 | ($3.59M) | Apr 12, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.45M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($5.79M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($632.6K) | Aug 29, 2025 |
| FY2023 | Dec 31, 2022 | ($1.39M) | Apr 12, 2024 |
| FY2022 | Dec 31, 2021 | ($600.1K) | Apr 12, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.9K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $55.3K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $4.3K | Aug 29, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.41M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $19.99M | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | $22.30M | Aug 29, 2025 |
| FY2024 | Jun 30, 2024 | $78.59M | Aug 29, 2025 |
| FY2024 | Dec 31, 2023 | $805.8K | Aug 29, 2025 |
| FY2023 | Dec 31, 2022 | $7.63M | Apr 12, 2024 |
| FY2022 | Dec 31, 2021 | $117.94M | Apr 12, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.96M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $20.01M | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | $21.37M | Aug 29, 2025 |
| FY2024 | Jun 30, 2024 | $25.48M | Aug 29, 2025 |
| FY2024 | Mar 31, 2024 | $5.64M | Aug 29, 2025 |
| FY2024 | Dec 31, 2023 | $5.11M | Aug 29, 2025 |
| FY2024 | Sep 30, 2023 | $5.04M | Aug 29, 2025 |
| FY2024 | Mar 31, 2023 | $3.92M | Aug 29, 2025 |
| FY2023 | Dec 31, 2022 | $7.67M | Apr 12, 2024 |
| FY2022 | Dec 31, 2021 | $4.55M | Apr 12, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($12.27M) | Apr 12, 2024 |
| FY2023 | Dec 31, 2022 | ($7.43M) | Apr 12, 2024 |
| FY2023 | Dec 31, 2021 | ($3.33M) | Apr 12, 2024 |
| FY2022 | Mar 29, 2021 | $0 | Apr 12, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.92M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $4.92M | Mar 31, 2026 |
| FY2024 | Jun 30, 2024 | $61.59M | Aug 29, 2025 |
| FY2024 | Jun 24, 2024 | $61.59M | Aug 29, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($82.42M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($67.70M) | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | ($64.50M) | Aug 29, 2025 |
| FY2024 | Jun 30, 2024 | ($10.57M) | Aug 29, 2025 |
| FY2024 | Mar 31, 2024 | ($9.94M) | Aug 29, 2025 |
| FY2024 | Dec 31, 2023 | ($10.00M) | Aug 29, 2025 |
| FY2024 | Sep 30, 2023 | ($7.44M) | Aug 29, 2025 |
| FY2024 | Mar 31, 2023 | ($6.76M) | Aug 29, 2025 |
| FY2024 | Dec 31, 2022 | ($6.24M) | Aug 29, 2025 |
| FY2022 | Dec 31, 2021 | ($3.33M) | Apr 12, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.27M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $326.1K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $118.7K | Aug 29, 2025 |
| FY2023 | Dec 31, 2022 | $107.0K | Apr 12, 2024 |
| FY2022 | Dec 31, 2021 | $760.0K | Apr 12, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.74M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.93M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $220.0K | Aug 29, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (5) | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | (3) | Aug 29, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Aug 29, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Aug 29, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Aug 29, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Aug 29, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Aug 29, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 12, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (5) | Mar 31, 2026 |
| FY2024 | Sep 30, 2024 | (3) | Aug 29, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Aug 29, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Aug 29, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Aug 29, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Aug 29, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Aug 29, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Aug 29, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 12, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 33.19M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 16.30M | Mar 31, 2026 |
| FY2024 | Jun 25, 2024 | 14.69M | Aug 29, 2025 |
| FY2025 | Jun 24, 2024 | 14.69M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 4.64M | Aug 29, 2025 |
| FY2022 | Oct 20, 2022 | 4.16M | Apr 12, 2023 |